Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.
Rihito AizawaKenji TakayamaKiyonao NakamuraTakahiro InoueToshinari YamasakiTakashi KobayashiShusuke AkamatsuOsamu OgawaTakashi MizowakiPublished in: International journal of clinical oncology (2019)
High-dose IMRT combined with short-term NA-ADT resulted in long-term disease-free status, with acceptable morbidity among approximately three-fourths of the HR PCa patients and nearly half of the VHR PCa patients. Moreover, excellent survival outcomes were achieved by the early S-ADT initiation. This approach may be a promising alternative to uniform provision of long-term ADT.